A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer | MicrobiomeTrials← Back to trialsNCT05599685
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
CompletedOBSERVATIONAL
Trial Details
Start: 2022-10-19Est. Completion: 2025-09-16
Enrollment target: 302 participants Locations- Local Institution - 0001, Athens, Greece
Other microbiome trials you might be interested in
Metastatic Non-Squamous Non-Small Cell Lung CancerAdult Solid Tumor
This is an exploratory, signal-finding, randomized, placebo-controlled, blinded, multi-center phase 2b trial of the anti…
Birmingham, United StatesEst. completion Oct 1, 2029
SCLCExtensive-stage Small Cell Lung Cancer
The purpose of this Medical Access Program (also referred to as an Expanded Access Program in the USA) is to provide acc…
Salina, United States
Recruiting
Prospective, biological, observational study involving the collection and use of samples from patients suffering from NS…
Rome, ItalyEst. completion Jul 24, 2026